A globally recognized leader in veterinary extracorporeal therapy (ECT), Dr. Cowgill will collaborate with the AimaLojic team to advance the use and development of its carbon hemoperfusion technology for treating severe toxicities in veterinary medicine
Hemoperfusion is an extracorporeal treatment technique in which blood is circulated outside the body through a filter to remove toxins and other undesired substances. This treatment offers a significant improvement over the current standard of care for severe toxicity, allowing for faster removal of toxins (as little as 90 minutes) to prevent long-term organ damage. Compared to other extracorporeal therapies such as dialysis and therapeutic plasma exchange, carbon hemoperfusion can also treat the widest range of common toxicities, often at a lower cost.